Bitonti R, Demma F, Rea M, Furneri G. Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test. AboutOpen [Internet]. 2022 Nov. 24 [cited 2024 Apr. 24];9(1):105-11. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2447